Fund Holdings — Sofinnova Investments, Inc.

Total Portfolio Value:
$1.59B
Total Bought:
$468.70M
Total Sold:
$429.10M
Net Transaction:
+$39.60M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Natera, Inc.(NTRA)1,550,2801,550,2800$141.79M$167.88M10.58%+$26.09M
Vera Therapeutics, Inc.CL A(VERA)2,793,9872,793,9870$120.48M$101.09M6.37%-$19.39M
Ascendis Pharma A/SADR(ASND)754,032734,284-19,748$113.99M$100.14M6.31%-$13.85M
Novo Nordisk A/SADR(NVO)611,884649,541+37,657$78.57M$92.72M5.84%+$14.15M
Edwards Lifesciences Corp0724,225+724,225$0$66.90M4.22%+$66.90M
Stryker Corporation(SYK)0193,084+193,084$0$65.70M4.14%+$65.70M
AstraZeneca PLCADR(AZN)596,713801,417+204,704$40.43M$62.50M3.94%+$22.08M
Dyne Therapeutics, Inc.(DYN)1,936,6501,625,703-310,947$54.98M$57.37M3.62%+$2.39M
Align Technology Inc95,478218,524+123,046$31.31M$52.76M3.32%+$21.45M
Rapport Therapeutics, Inc.(RAPP)01,951,562+1,951,562$0$45.39M2.86%+$45.39M
Syndax Pharmaceuticals, Inc.(SNDX)1,608,5402,153,669+545,129$38.28M$44.21M2.79%+$5.93M
Elanco Animal Health Incorporated(ELAN)2,555,5472,864,250+308,703$41.60M$41.33M2.60%-$273.2K
IDEAYA Biosciences, Inc.(IDYA)781,5961,151,528+369,932$34.30M$40.43M2.55%+$6.13M
Intuitive Surgical, Inc.(ISRG)140,88087,217-53,663$56.22M$38.80M2.44%-$17.43M
Alnylam Pharmaceuticals, Inc.(ALNY)103,036147,929+44,893$15.40M$35.95M2.27%+$20.55M
TG Therapeutics, Inc.(TGTX)1,984,9621,861,277-123,685$30.19M$33.11M2.09%+$2.92M
ArriVent BioPharma, Inc.(AVBP)1,696,7521,696,7520$30.30M$31.47M1.98%+$1.17M
IDEXX Laboratories, Inc.(IDXX)75,22463,862-11,362$40.62M$31.11M1.96%-$9.50M
Sarepta Therapeutics, Inc.(SRPT)227,488195,852-31,636$29.45M$30.94M1.95%+$1.49M
Y-mAbs Therapeutics Inc2,194,2782,194,2780$35.68M$26.51M1.67%-$9.17M
Axsome Therapeutics, Inc.(AXSM)0310,198+310,198$0$24.97M1.57%+$24.97M
Cogent Biosciences, Inc.(COGT)2,400,7712,773,286+372,515$16.13M$23.38M1.47%+$7.25M
Soleno Therapeutics Inc150,775554,359+403,584$6.45M$22.62M1.43%+$16.16M
Savara Inc.(SVRA)2,347,2615,358,918+3,011,657$11.69M$21.60M1.36%+$9.91M
Celldex Therapeutics, Inc.(CLDX)801,777547,707-254,070$33.65M$20.27M1.28%-$13.38M
Roivant Sciences Ltd.SHS(ROIV)1,001,7041,868,412+866,708$10.56M$19.75M1.24%+$9.19M
Establishment Labs Holdings Inc.(ESTA)141,162429,244+288,082$7.19M$19.50M1.23%+$12.32M
Inozyme Pharma Inc4,280,3084,280,3080$32.79M$19.09M1.20%-$13.70M
Revolution Medicines, Inc.(RVMD)0455,099+455,099$0$17.66M1.11%+$17.66M
Kura Oncology, Inc.(KURA)501,940825,243+323,303$10.71M$16.99M1.07%+$6.29M
Insmed Incorporated(INSM)0227,747+227,747$0$15.26M0.96%+$15.26M
Boston Scientific Corporation(BSX)353,851171,080-182,771$24.24M$13.17M0.83%-$11.06M
Madrigal Pharmaceuticals, Inc.(MDGL)19,02944,417+25,388$5.08M$12.44M0.78%+$7.36M
Insulet Corporation(PODD)220,20360,967-159,236$37.74M$12.30M0.78%-$25.44M
Pharvaris N V
COM
584,672601,534+16,862$13.51M$11.31M0.71%-$2.20M
Axonics Inc149,385150,490+1,105$10.30M$10.12M0.64%-$185.6K
Immatics N.V.SHS(IMTX)2,163,646796,704-1,366,942$22.74M$9.26M0.58%-$13.48M
Cabaletta Bio, Inc.(CABA)429,7461,220,400+790,654$7.33M$9.13M0.58%+$1.80M
PepGen Inc.(PEPG)503,624561,128+57,504$7.40M$8.96M0.56%+$1.55M
Edgewise Therapeutics, Inc.(EWTX)0475,691+475,691$0$8.57M0.54%+$8.57M
Immunome, Inc.(IMNM)594,396655,680+61,284$14.67M$7.93M0.50%-$6.74M
Endeavour Silver Corp.(EXK)229,481181,828-47,653$15.85M$7.68M0.48%-$8.17M
Inari Med Inc10,216155,838+145,622$490.2K$7.50M0.47%+$7.01M
DexCom, Inc.(DXCM)061,494+61,494$0$6.97M0.44%+$6.97M
Inhibrx Biosciences, Inc.(INBX)0463,315+463,315$0$6.57M0.41%+$6.57M
Achieve Life Sciences Inc1,518,2301,388,372-129,858$6.90M$6.53M0.41%-$375.0K
Waters Corporation(WAT)021,804+21,804$0$6.33M0.40%+$6.33M
Aerovate Therapeutics Inc3,758,6863,758,6860$111.14M$6.24M0.39%-$104.90M
4D Molecular Therapeutics Inc198,186271,155+72,969$6.31M$5.69M0.36%-$622.7K
Marinus Pharmaceuticals Inc1,401,0534,151,576+2,750,523$12.67M$4.86M0.31%-$7.81M
Nextcure Inc2,671,8562,671,8560$5.96M$4.25M0.27%-$1.71M
Erasca, Inc.(ERAS)01,699,528+1,699,528$0$4.01M0.25%+$4.01M
Phibro Animal Health CorporationCL A(PAHC)0237,009+237,009$0$3.97M0.25%+$3.97M
Baxter Intl Inc20,000117,769+97,769$854.8K$3.94M0.25%+$3.08M
Avantor, Inc.(AVTR)232,446141,045-91,401$5.94M$2.99M0.19%-$2.95M
Teleflex Incorporated(TFX)12,14213,649+1,507$2.75M$2.87M0.18%+$124.6K
Masimo Corp20,00020,161+161$2.94M$2.54M0.16%-$397.9K
Bolt Biotherapeutics Inc2,754,4372,754,4370$3.86M$2.07M0.13%-$1.79M
Inspire Medical Systems, Inc.(INSP)8,09910,000+1,901$1.74M$1.34M0.08%-$401.3K
Disc Medicine, Inc.(IRON)6,17329,256+23,083$384.3K$1.32M0.08%+$934.2K
Perspective Therapeutics, Inc.(CATX)0132,089+132,089$0$1.32M0.08%+$1.32M
Zimmer Biomet Holdings, Inc.(ZBH)010,630+10,630$0$1.15M0.07%+$1.15M
LivaNova PLCSHS(LIVN)20,45620,602+146$1.14M$1.13M0.07%-$14.9K
Immatics N.VW EXP 07 01 2025316,349348,731+32,382$853.1K$932.9K0.06%+$79.8K
Avidity Biosciences Inc021,425+21,425$0$875.2K0.06%+$875.2K
Ikena Oncology Inc382,616382,6160$543.3K$631.3K0.04%+$88.0K
Amylyx Pharmaceuticals, Inc.(AMLX)306,729299,691-7,038$871.1K$569.4K0.04%-$301.7K
Astria Therapeutics Inc060,692+60,692$0$552.3K0.03%+$552.3K
PDS Biotechnology Corporation(PDSB)142,635142,6350$564.8K$417.9K0.03%-$146.9K
Pulmonx Corporation(LUNG)060,246+60,246$0$382.0K0.02%+$382.0K
Kyverna Therapeutics, Inc.(KYTX)10,00047,850+37,850$248.4K$358.9K0.02%+$110.5K
Structure Therapeutics IncADS8,7338,915+182$374.3K$350.1K0.02%-$24.2K
argenx SEADR(ARGX)149,3000-149,300$58.78M$0—-$58.78M
The Cooper Companies, Inc.(COO)21,2360-21,236$2.15M$0—-$2.15M
Fusion Pharmaceuticals Inc157,1720-157,172$3.35M$0—-$3.35M
Incyte Corporation(INCY)1,327,1780-1,327,178$75.61M$0—-$75.61M
Inhibrx Inc1,302,6450-1,302,645$45.54M$0—-$45.54M
Merck & Co., Inc.(MRK)651,2990-651,299$85.94M$0—-$85.94M
Mirum Pharmaceuticals, Inc.(MIRM)3,0120-3,012$75.7K$0—-$75.7K
Perspective Therapeutics, Inc.(CATX)430,1050-430,105$511.8K$0—-$511.8K
Shockwave Med Inc35,0000-35,000$11.40M$0—-$11.40M
Silk Rd Med Inc1,189,0240-1,189,024$21.78M$0—-$21.78M
Nucana PLCADR3,400,7390-3,400,739$884.2K$0—-$884.2K
Nucana PLC1,307,8750-1,307,875$340.0K$0—-$340.0K
Page 1 of 1
Sofinnova Investments, Inc. — 13F Holdings — Q2 2024 | TickerTrail